Multiple Choice
The Final Privacy Rule requires a covered entity to obtain an individual's prior written authorization to use his or her PHI for marketing purposes except for:
A) Situations where the marketing is for a drug or treatment could improve the health of that individual.
B) Situations where the patient has already signed the covered entity's Notice of Privacy Practices.
C) A face-to-face encounter with the sales person of a company that provides drug samples.
D) A communication involving a promotional gift of nominal value.
E) The situation where the patient has signed the Notice of Privacy Practices of the marketer.
Correct Answer:

Verified
Correct Answer:
Verified
Q69: The National Provider Identifier (NPI) will eventually
Q73: This code set describes drugs:<br>A) ICD-9-CM, Volumes
Q74: The Security Rule requires that the covered
Q75: Which of the following is example of
Q76: Select the FALSE statement regarding the X12N
Q79: Which of the following is NOT a
Q80: Which of the following is a required
Q81: This transaction is the response to a
Q82: This transaction type is a "response" transaction
Q83: Select the correct statement regarding the requirements